Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 35OTHER_GOV 3INDUSTRY 3UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Colorectal Neoplasms 12Esophageal Squamous Cell Carcinoma 6Carcinoma, Hepatocellular 5Colonic Neoplasms 3Radiation Injuries 2Urinary Bladder Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Locally Advanced Pancreatic Cancer 1Liver Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1HER2-positive 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Extrapancreatic Neuroendocrine Tumor 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Anus Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Gastric Adenocarcinoma × Gastrointestinal × Clear all
NCT02512380 2015-08-10

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

ChineseAMS

Phase 3 Unknown
380 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡